Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Metagenomi, Inc. - Common Stock (NQ:MGX)

1.480 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,773
Open 1.480
Bid (Size) 1.400 (14)
Ask (Size) 1.480 (1)
Prev. Close 1.480
Today's Range 1.480 - 1.480
52wk Range 1.460 - 10.94
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Metagenomi Reports Business Updates and Full Year 2024 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week
Positive data from clinical trials, earnings readouts, M&A speculation and new research drew heavy interest from retail traders on Stocktwits for these tickers for the week ended March 14, 2025. 
Via Stocktwits

Performance

YTD
-60.9%
-60.9%
1 Month
-27.8%
-27.8%
3 Month
-58.0%
-58.0%
6 Month
-31.8%
-31.8%
1 Year
-86.3%
-86.3%

More News

Read More
Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems
From Metagenomi, Inc.
Via GlobeNewswire
Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference
From Metagenomi, Inc.
Via GlobeNewswire
Expert Outlook: Metagenomi Through The Eyes Of 4 Analysts
Via Benzinga
Stargate, Netflix, GE Aerospace, Twilio, and More
Via The Motley Fool
Trump’s “Stargate AI” Healthcare/Medical Watch: CSDX, IPA, MGX, CDIO
Via AB Newswire
Topics Artificial Intelligence Government
Exposures Artificial Intelligence Political
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones
From Metagenomi, Inc.
Via GlobeNewswire
Metagenomi Announces New Appointment to its Board of Directors
From Metagenomi, Inc.
Via GlobeNewswire
Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Metagenomi, Inc.
Via GlobeNewswire
Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”
From Metagenomi, Inc.
Via GlobeNewswire
Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting
From Metagenomi, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
FINAL DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi
From Faruqi & Faruqi, LLP
Via Business Wire
MGX Deadline: Rosen Law Firm Urges Metagenomi, Inc. (NASDAQ: MGX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Metagenomi, Inc. (MGX)
From The Law Offices of Frank R. Cruz
Via Business Wire
DEADLINE NEXT WEEK: Berger Montague Advises Metagenomi (NASDAQ: MGX) Investors to Contact the Firm Before November 25, 2024
From Berger Montague
Via GlobeNewswire
METAGENOMI, INC. (NASDAQ: MGX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Metagenomi, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
METAGENOMI ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Metagenomi, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi
From Faruqi & Faruqi LLP
Via GlobeNewswire
METAGENOMI (NASDAQ: MGX) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by November 25, 2024
From Berger Montague
Via GlobeNewswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi
From Faruqi & Faruqi LLP
Via GlobeNewswire
Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results
From Metagenomi, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Metagenomi, Inc. - Common Stock publicly traded?
Yes, Metagenomi, Inc. - Common Stock is publicly traded.
What exchange does Metagenomi, Inc. - Common Stock trade on?
Metagenomi, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Metagenomi, Inc. - Common Stock?
The ticker symbol for Metagenomi, Inc. - Common Stock is MGX on the Nasdaq Stock Market
What is the current price of Metagenomi, Inc. - Common Stock?
The current price of Metagenomi, Inc. - Common Stock is 1.480
When was Metagenomi, Inc. - Common Stock last traded?
The last trade of Metagenomi, Inc. - Common Stock was at 03/28/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.